Homoarginine in the cardiovascular system: Pathophysiology and recent developments

Upcoming experimental and epidemiological data have identified the endogenous non‐proteinogenic amino acid L‐homoarginine (L‐hArg) not only as a novel biomarker for cardiovascular disease but also as being directly involved in the pathogenesis of cardiac dysfunction. The association of low L‐hArg le...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Fundamental & clinical pharmacology 2023-06, Vol.37 (3), p.519-529
Hauptverfasser:	Koch, Vitali, Gruenewald, Leon D., Gruber‐Rouh, Tatjana, Eichler, Katrin, Leistner, David M., Mahmoudi, Scherwin, Booz, Christian, Bernatz, Simon, D'Angelo, Tommaso, Albrecht, Moritz H., Alizadeh, Leona S., Nour‐Eldin, Nour‐Eldin A., Scholtz, Jan‐Erik, Yel, Ibrahim, Vogl, Thomas J., März, Winfried, Hardt, Stefan E., Martin, Simon S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Amino acids Arginine - metabolism Biomarkers cardiovascular Cardiovascular disease Cardiovascular diseases Cardiovascular Diseases - diagnosis Cardiovascular System Dietary supplements Epidemiology Health risks Homoarginine Humans Metabolism mortality nitric oxide Pathogenesis Pathophysiology Pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!